Back to Top Skip to main content the official website of the Military Health System (MHS) and the Defense Health Agency (DHA)

Utility Navigation Links

TRICARE Policy Manual 6010.63-M, April 2021
Chapter 1
Section 6.1
Special Authorization Requirements
Issue Date:  August 4, 1988
1.0  Policy
Unless otherwise specifically excepted, the adjudication of the following types of care is subject to the following authorization requirements:
1.1  Adjunctive dental care must be preauthorized.
1.2  Dental anesthesia and institutional benefit must be preauthorized. See Chapter 8, Section 13.2.
1.3  Extended Care Health Option (ECHO) benefits must be authorized in accordance with Chapter 9, Section 4.1.
1.4  Effective October 1, 1991, preadmission and continued stay authorization is required before nonemergency inpatient mental health services may be cost-shared (includes Residential Treatment Center (RTC) care and inpatient/residential Substance Use Disorder (SUD) detoxification and rehabilitation).
1.5  Effective November 18, 1991, psychoanalysis must be preauthorized.
1.6  The Government Designated Authority (GDA), may require preauthorization of admission to nonemergency inpatient facilities.
1.7  Organ and stem cell transplants are required to be preauthorized. For organ and stem cell transplants, the preauthorization shall remain in effect as long as the beneficiary continues to meet the specific transplant criteria set forth in this TRICARE Policy Manual (TPM), or until the approved transplant occurs.
1.8  Infusion therapy delivered in the home must be preauthorized in accordance with Chapter 8, Section 20.1.
1.9  Effective for dates of service June 1, 2010, Skilled Nursing Facility (SNF) care received in the United States (US) and US territories must be preauthorized for TRICARE dual eligible beneficiaries. The TRICARE Medicare Eligible Program (TMEP) contractor shall preauthorize SNF care beginning on day 101, when TRICARE becomes primary payer. For those beneficiaries inpatient on the effective date, a preauthorization will be required August 1, 2010. See the TRICARE Operations Manual (TOM), Chapter 7, Section 2 and the TRICARE Reimbursement Manual (TRM), Chapter 8, Section 1.
1.10  Provisional coverage for emerging service and supplies shall be preauthorized, when required, in accordance with Chapter 13, Section 1.1 and TOM, Chapter 7, Section 4.
1.11  Medically necessary low protein modified foods for the treatment of inborn errors of metabolism shall be preauthorized in accordance with Chapter 8, Section 7.1.
1.12  Each TRICARE contractor may require additional care authorizations not identified in this section. Such authorization requirements may differ between geographic areas of responsibility. Beneficiaries and providers are responsible for contacting their contractor for a listing of additional authorization requirements in their geographic area.
1.13  The contractor shall perform medically necessary reviews on a retrospective basis when it determines a review is needed (to act as a secondary payor) when a beneficiary has “other insurance” that provides primary coverage. The preauthorization requirements in paragraph 1.12. will not apply. The conditions for applying this exception are:
•  The Other Health Insurance (OHI) must be primary under the provisions of the TRM, Chapter 4, Section 1.
•  Documentation that the OHI processed the claim and of the exact amount paid must be submitted with the TRICARE claim.
1.14  Provider payments are reduced for the failure to comply with the preauthorization requirements for certain types of care. See the TRM, Chapter 1, Section 28.
1.15  Effective March 5, 2019, Spravato™ (esketamine) nasal spray shall require preauthorization under the medical benefit in accordance with Chapter 7, Section 3.7 and TOM, Chapter 7, Section 2.
The contractor shall obtain the necessary information and perform a retrospective review when TRICARE is primary payer for these services and preauthorization was not obtained. For dual eligible beneficiaries, these requirements apply when TRICARE is primary payer. As secondary payer, TRICARE will rely on and not replicate Medicare’s determination of medical necessity and appropriateness in all circumstances where Medicare is primary payer.
- END -

Utility Navigation Links

DoD Seal is the official website of the Defense Health Agency (DHA) a component of the Military Health System

TRICARE is a registered trademark of the Department of Defense (DoD), DHA. All rights reserved.

CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.

If you have a question regarding TRICARE benefits, please go to the TRICARE Contact Us page page.
If you need help with technical/operational issues, please go to the TRICARE Manuals Online Help page.

The appearance of hyperlinks to external websites does not constitute endorsement by the DHA of these websites or the information, products or services contained therein. For other than authorized government activities, the DHA does not exercise any editorial control over the information you may find at other locations. Such links are provided consistent with the stated purpose of this DoD website.


DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.